Task: Answer the multiple choice question.
Query: Which drug exhibits a -50.131% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCN1CCN(c2cc(C)c3cc(NC(=S)N4CCCCC4)ccc3n2)CC1
b.) N=c1c(C(=O)NC2CCCC2)cc2c(=O)n3ccccc3nc2n1Cc1ccccc1Cl
Answer: a. CCN1CCN(c2cc(C)c3cc(NC(=S)N4CCCCC4)ccc3n2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2cc(C)c3cc(NC(=S)N4CCCCC4)ccc3n2)CC1
CCN1CCN(c2cc(C)c3cc(NC(=S)N4CCCCC4)ccc3n2)CC1
N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]piperidine-1-carbothioamide